FDA Import Refusal 799-5567770-0/21/1 — GLAXO SMITHKLINE
The FDA refused shipment 799-5567770-0/21/1 from GLAXO SMITHKLINE (India) on Apr 20, 2018. The refused product falls under Drugs and Biologics — CEPHALEXIN HYDROCHLORIDE (CEPHALOSPORINS). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 20, 2018
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56CCE73 CEPHALEXIN HYDROCHLORIDE (CEPHALOSPORINS)
- Charges
- 75